NAFLD mice exhibited elevated levels of p-NF-κB, NLRP3, ASC, Caspase-1, Cleaved-Caspase-1, and Cleaved-IL-1β in liver tissues, all of which were downregulated upon HH treatment. The gene discussed is CASP1; the disease is metabolic dysfunction-associated steatotic liver disease.